| 产品编号 | bsm-43105M |
| 英文名称 | PCSK9 Mouse mAb |
| 中文名称 | 神经细胞凋亡调节转化蛋白1/前蛋白转化酶枯草溶菌素9单克隆抗体 |
| 别 名 | FH3; FHCL3; HCHOLA3; LDLCQ1; NARC-1; NARC1; PC9; PCSK9_HUMAN; PCSK9; Neural apoptosis-regulated convertase 1 (NARC-1); Proprotein convertase 9 (PC9); Subtilisin/kexin-like protease PC9; 3.4.21.-; PCSK9_MOUSE; PCSK9_RAT; 神经细胞凋亡调节转化蛋白1/前蛋白转化酶枯草溶菌素9 |
| 抗体来源 | Mouse |
| 克隆类型 | Monoclonal |
| 克 隆 号 | 5A11 |
| 交叉反应 | (predicted: Mouse, Rat, ) |
| 产品应用 | ELISA=1:5000-10000
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 理论分子量 | 57 kDa |
| 细胞定位 | 分泌型蛋白 |
| 性 状 | Liquid |
| 免 疫 原 | Recombinant human PCSK9 protein: 31-692/692 |
| 亚 型 | |
| 纯化方法 | affinity purified by Protein A |
| 缓 冲 液 | PBS (pH=7.4). |
| 保存条件 | Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| PubMed | PubMed |
| 产品介绍 |
May be implicated in the differentiation of cortical neurons and may play a role in cholesterol homeostasis. Function: The precursor protein but not the mature protein may form multimers. Subunit: The precursor protein but not the mature protein may form multimers. Subcellular Location: Secreted. Tissue Specificity: Expressed in neuro-epithelioma, colon carcinoma, hepatic and pancreatic cell lines, and in Schwann cells. Post-translational modifications: The soluble zymogen undergoes autocatalytic intramolecular processing in the endoplasmic reticulum, resulting in the cleavage of its propeptide that remains associated with the secreted enzyme. Similarity: Belongs to the peptidase S8 family. Contains 1 peptidase S8 domain. SWISS: Q8NBP7 Gene ID: 255738 Database links: Entrez Gene: 255738 Human Entrez Gene: 100102 Mouse Omim: 607786 Human SwissProt: Q8NBP7 Human SwissProt: Q80W65 Mouse Unigene: 18844 Human Unigene: 133268 Mouse Unigene: 19195 Rat 前蛋白转化酶枯草溶菌素9(PCSK9)是近年来新发现的一种与调节脂质代谢密切相关的基因,编码前蛋白转化酶NARC-1。Narc-1/pcsk9可通过调节细胞表面的低密度脂蛋白受体(LDLR)水平,参与脂质代谢,从而在动脉粥样硬化性疾病的发生、发展中发挥重要作用。 |
| 产品图片 |
Sample:
Lane 1: Recombinant human PCSK9 protein, C-His (HEK293)(bs-43105P)
Primary: Anti-PCSK9 (bsm-43105M) at 1/1000 dilution
Secondary: IRDye800CW Goat Anti-Mouse IgG at 1/20000 dilution
Predicted band size: 57 kDa
Observed band size: 67 kDa
|
| 1、抗体溶解方法 | |
| 2、抗体修复方式 | |
| 3、常用试剂的配制 | |
| 4、免疫组化操作步骤 | |
| 5、免疫组化问题解答 | |
| 6、Western Blotting 操作步骤 | |
| 7、Western Blotting 问题解答 | |
| 8、关于肽链的设计 | |
| 9、多肽的溶解与保存 | |
| 10、酶标抗体效价测定程序 | |
